Date Filed | Type | Description |
10/03/2023 |
4
| Tosca Melissa (EVP Finance) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 30,000 shares
@ $0 Granted 60,000 options to buy
@ $0.5677, valued at
$34.1k
|
|
10/03/2023 |
4
| Daniels Eric Joseph (Chief Development Officer) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 62,500 shares
@ $0 Granted 125,000 options to buy
@ $0.5677, valued at
$71k
|
|
10/03/2023 |
4
| Strem Brian M. (President and CEO) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 75,000 shares
@ $0 Granted 150,000 options to buy
@ $0.5677, valued at
$85.2k
|
|
10/03/2023 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 5,000 options to buy
@ $0.5677, valued at
$2.8k
|
|
10/03/2023 |
4
| Shapiro Aron (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 5,000 options to buy
@ $0.5677, valued at
$2.8k
|
|
10/03/2023 |
4
| Stengone Carmine N. (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 8,000 options to buy
@ $0.5677, valued at
$4.5k
|
|
10/03/2023 |
4
| Hollander David (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted options to buy
@ $0.5677, valued at
$0 |
|
10/03/2023 |
4
| Gayron Kenneth L (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 5,000 options to buy
@ $0.5677, valued at
$2.8k
|
|
10/03/2023 |
4
| Parsons Erin (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 5,000 options to buy
@ $0.5677, valued at
$2.8k
|
|
08/10/2023 |
3
| Stengone Carmine N. (Director) has filed a Form 3 on KIORA PHARMACEUTICALS INC |
03/07/2023 |
4
| Parsons Erin (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
03/07/2023 |
4
| Tosca Melissa (EVP Finance) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 2,400 shares
@ $0 Granted 1,600 options to buy
@ $3.83, valued at
$6.1k
|
|
03/07/2023 |
4
| Strem Brian M. (President and CEO) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 15,600 shares
@ $3.83, valued at
$59.7k
Granted 10,400 options to buy
@ $3.83, valued at
$39.8k
|
|
03/07/2023 |
4
| Daniels Eric Joseph (Chief Development Officer) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 15,600 shares
@ $0 Granted 10,400 options to buy
@ $3.83, valued at
$39.8k
|
|
03/07/2023 |
4
| Gayron Kenneth L (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
03/07/2023 |
4
| Shapiro Aron (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
03/07/2023 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
03/07/2023 |
4
| Hollander David (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
03/07/2023 |
4
| CHANEY PAUL G (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 8,000 options to buy
@ $3.83, valued at
$30.6k
|
|
10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/22/2022 |
3
| Tosca Melissa (EVP of Finance) has filed a Form 3 on KIORA PHARMACEUTICALS INC |
05/02/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/11/2022 |
4
| Romano Sarah (CFO) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 108 shares
@ $0.69, valued at
$74.5 |
|
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2022 |
4
| TYLE PRAVEEN (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 5,000 options to buy
@ $0.77, valued at
$3.9k
|
|
02/03/2022 |
4
| CHANEY PAUL G (Director) has filed a Form 4 on KIORA PHARMACEUTICALS INC
Txns:
| Granted 5,000 options to buy
@ $0.77, valued at
$3.9k
|
|
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|